Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AEye (LIDR) Asset Writedowns and Impairment: 2021-2025

Historic Asset Writedowns and Impairment for AEye (LIDR) over the last 1 years, with Jun 2025 value amounting to $2,000.

  • AEye's Asset Writedowns and Impairment was N/A to $2,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $35,000 for FY2024, which is 99.65% down from last year.
  • According to the latest figures from Q2 2025, AEye's Asset Writedowns and Impairment is $2,000, which was down 85.71% from $14,000 recorded in Q1 2024.
  • AEye's 5-year Asset Writedowns and Impairment high stood at $9.9 million for Q4 2023, and its period low was $2,000 during Q2 2025.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $47,000 (2023), whereas its average is $2.0 million.
  • In the last 5 years, AEye's Asset Writedowns and Impairment surged by 9,941.41% in 2023 and then crashed by 93.27% in 2024.
  • AEye's Asset Writedowns and Impairment (Quarterly) stood at $1.2 million in 2021, then tumbled by 91.77% to $99,000 in 2022, then soared by 9,941.41% to $9.9 million in 2023, then plummeted by 93.27% to $14,000 in 2024, then reached $2,000 in 2025.
  • Its Asset Writedowns and Impairment stands at $2,000 for Q2 2025, versus $14,000 for Q1 2024 and $9.9 million for Q4 2023.